Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Venture Global shares jump as court rejects Shell′s challenge to LNG ruling (Reuters EN) +++ VENTURE GLOBAL Aktie -3,07%

MEDLINE Aktie

 >MEDLINE Aktienkurs 
37.2 EUR    (TradegateBSX)
Ask: 37.8 EUR / 140 Stück
Bid: 36.6 EUR / 140 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MEDLINE Aktie über LYNX handeln
>MEDLINE Performance
1 Woche: -3,8%
1 Monat: +5,3%
3 Monate: 0%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>MEDLINE Aktie
Name:  MEDLINE INC. CL. A O.N.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US58507V1070 / A41V2L
Symbol/ Ticker:  L10 (Frankfurt) / MDLN (NASDAQ)
Kürzel:  FRA:L10, ETR:L10, L10:GR, NASDAQ:MDLN
Index:  -
Webseite:  https://ir.medline.com/
Profil:  Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It..
>Volltext..
Marktkapitalisierung:  52829.51 Mio. EUR
Unternehmenswert:  69507.55 Mio. EUR
Umsatz:  24066.06 Mio. EUR
EBITDA:  2765.33 Mio. EUR
Nettogewinn:  981.03 Mio. EUR
Gewinn je Aktie:  1.22 EUR
Schulden:  11014.76 Mio. EUR
Liquide Mittel:  1643.79 Mio. EUR
Operativer Cashflow:  1476.2 Mio. EUR
Bargeldquote:  0.78
Umsatzwachstum:  -1.75%
Gewinnwachstum:  -14.87%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  MEDLINE
Letzte Datenerhebung:  03.03.26
>MEDLINE Kennzahlen
Aktien/ Unternehmen:
Aktien: 811.65 Mio. St.
Frei handelbar: 55.45%
Leerverk. Aktien: -
Rückkaufquote: -8.03%
Mitarbeiter: 45000
Umsatz/Mitarb.: 0.53 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 10.21%
Bewertung:
KGV: 32.82
KGV lG: 32.44
KUV: 1.44
KBV: 3.59
PEG-Ratio: -
EV/EBITDA: 25.14
Rentabilität:
Bruttomarge: 23.97%
Gewinnmarge: 4.08%
Operative Marge: 7.93%
Managementeffizenz:
Gesamtkaprendite: 3.11%
Eigenkaprendite: 8.5%
>MEDLINE Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
03.03.26 - 14:27
Medline stock dips after $75M-share secondary offering by holders (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.03.26 - 14:02
Medline-Aktie fällt: Großinvestoren leiten Verkauf von 75 Millionen Aktien ein/n (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
03.03.26 - 13:48
Medline′s PE Backers Start Stake Sale Worth $3.4 Billion (Bloomberg)
 
Medline Inc. shareholders are offering 75 million shares in the company, capitalizing on a rally in the medical supplier's stock since its debut late last year....
03.03.26 - 13:06
Medline Inc. announces launch of secondary offering of Class A common stock (GlobeNewswire EN)
 
NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) have commenced an underwritten public offering of 75,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock....
27.02.26 - 22:15
The Analyst Verdict: Medline In The Eyes Of 29 Experts (Benzinga)
 
Importance Rank:  1 read more...
25.02.26 - 16:54
Medline Q4 2025: Umsatzwachstum überzeugt, doch Margendruck belastet die Aktie (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
25.02.26 - 13:42
Medline Inc. GAAP EPS of -$0.01 misses by $0.14, revenue of $7.8B beats by $290M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.02.26 - 13:33
Medline Reports Fourth Quarter and Full Year 2025 Results (GlobeNewswire EN)
 
NORTHFIELD, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care2, today reported its operating results for the three months and full year ended December 31, 2025....
24.02.26 - 19:45
Will Medline′s Q4 Earnings Validate Its Prime Vendor Growth Strategy? (Zacks)
 
MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results....
24.02.26 - 17:57
Medline Inc. Q4 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.26 - 13:33
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference (GlobeNewswire EN)
 
NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET....
05.02.26 - 07:49
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio (Fool)
 
Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history....
28.01.26 - 15:03
Medline to report fourth quarter and full year 2025 results on February 25, 2026 (GlobeNewswire EN)
 
NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results....
12.01.26 - 21:30
Medline Jumps as Analysts Turn Bullish After 2025′s Biggest IPO (Bloomberg)
 
Medline Inc. shares advanced Monday as Wall Street analysts struck a bullish tone on the medical supplier's business model and growth prospects following its $7.2 billion IPO last month....
12.01.26 - 20:12
Analysts initiate coverage on Medline after IPO, flag growth visibility and margin (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.01.26 - 07:48
Medline′s $25 bln supply chain scale wins Jefferies “buy” in coverage debut (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
07.01.26 - 20:42
Market Risk Appetite Put to the Test | Open Interest 1/7/2026 (Bloomberg)
 
Get a jump start on the US trading day with Matt Miller and Dani Burger on "Bloomberg Open Interest." Stocks lose steam as fresh ADP data kicks off a crucial week of economic reports — Washington tightens the screws on Venezuelan oil amid global tension from Greenland to China and Russia. Financials sit near record highs; we'll get a read from Jefferies, Wall Street's earnings bellwether. And Medline's blockbuster IPO — the largest private-equity backed debut ever — jumped over 40%. Carlyle Co-Head of Americas Corporate Private Equity, Steve Wise, joined Bloomberg Open Interest with his view of the IPO pipeline. (Source: Bloomberg)...
07.01.26 - 18:06
Inside Medline′s Record IPO (Bloomberg)
 
Debuting last month, Medline surged more than 40% in the biggest IPO of 2025. It was the largest private-equity-backed IPO ever backed by Blackstone, Carlyle, and Hellman & Friedman. Steve Wise, Carlyle Co-Head of Americas Corporate Private Equity, joined Bloomberg Open Interest to talk about the IPO pipeline, market momentum, and how geopolitics is reshaping dealmaking in 2026. (Source: Bloomberg)...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das Übel nährt sich nur von seinesgleichen. Weise Menschen vergalten daher nicht Böses mit Bösem, sondern immer nur mit Gutem und brachten dadurch das Böse zu Fall. - Mohandas
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!